Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-16-047513
Filing Date
2016-01-11
Accepted
2016-01-11 17:50:06
Documents
1
Period of Report
2015-02-09

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 8493
  Complete submission text file 0001140361-16-047513.txt   9909
Mailing Address C/O NEKTAR THERAPEUTICS 150 INDUSTRIAL ROAD SAN CARLOS CA 94070
Business Address
Elam Nevan C (Reporting) CIK: 0001314773 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-54495 | Film No.: 161337211

Mailing Address 1450 INFINITE DRIVE LOUISVILLE CO 80027
Business Address 1450 INFINITE DRIVE LOUISVILLE CO 80027 650-847-1919
AntriaBio, Inc. (Issuer) CIK: 0001509261 (see all company filings)

EIN.: 273440894 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations